205 related articles for article (PubMed ID: 35484112)
1. OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor.
Fan C; Wang Q; van der Zon G; Ren J; Agaser C; Slieker RC; Iyengar PV; Mei H; Ten Dijke P
Signal Transduct Target Ther; 2022 Apr; 7(1):126. PubMed ID: 35484112
[TBL] [Abstract][Full Text] [Related]
2. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
3. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation.
Fan C; Wang Q; Kuipers TB; Cats D; Iyengar PV; Hagenaars SC; Mesker WE; Devilee P; Tollenaar RAEM; Mei H; Ten Dijke P
EMBO J; 2023 May; 42(10):e112806. PubMed ID: 36994542
[TBL] [Abstract][Full Text] [Related]
5. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
Yuki R
Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
[TBL] [Abstract][Full Text] [Related]
6. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
7. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
8. ppGalNAc-T4-catalyzed O-Glycosylation of TGF-β type Ⅱ receptor regulates breast cancer cells metastasis potential.
Wu Q; Zhang C; Zhang K; Chen Q; Wu S; Huang H; Huang T; Zhang N; Wang X; Li W; Liu Y; Zhang J
J Biol Chem; 2021; 296():100119. PubMed ID: 33234595
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
10. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
[TBL] [Abstract][Full Text] [Related]
11. Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells.
Zhang J; van Dinther M; Thorikay M; Gourabi BM; Kruithof BPT; Ten Dijke P
Cell Mol Life Sci; 2023 Jan; 80(2):43. PubMed ID: 36646950
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
13. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
14. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent.
Hedrick E; Safe S
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674186
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins.
Avalle L; Incarnato D; Savino A; Gai M; Marino F; Pensa S; Barbieri I; Stadler MB; Provero P; Oliviero S; Poli V
Cell Death Differ; 2017 Oct; 24(10):1750-1760. PubMed ID: 28644441
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
18. MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.
Turcatel G; Rubin N; El-Hashash A; Warburton D
PLoS One; 2012; 7(1):e31032. PubMed ID: 22299047
[TBL] [Abstract][Full Text] [Related]
19. High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.
Zhang C; Han Y; Huang H; Qu L; Shou C
Breast Cancer Res Treat; 2014 Sep; 147(2):265-81. PubMed ID: 25129343
[TBL] [Abstract][Full Text] [Related]
20. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
